Valsartan Recalls Resulted In Significant Drop In Use, As Well As Confusion and Concerns Among Doctors, Patients
A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.…
A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
A panel of federal judges has ordered all losartan and irbesartan recall lawsuits folded into consolidated valsartan litigation.…
The FDA is investigating whether some metformin, a diabetes medication, may be contaminated with cancer-causing levels of NDMA.…
Following massive recalls issued world-wide last year, due to cancer causing impurities that contaminated generic valsartan drugs, researchers indicate that there was a significant spike in emergency room treatments among individuals who relied on the hypertension drug.…
Aurobindo reports that the FDA has found more problems at its India production facilities during inspections last month in the wake of valsartan recalls.…
Consumers should expect additional drug recalls due to NDMA contamination, according to a recent report.…
The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.…
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.…
The federal judge overseeing valsartan recall litigation has approved Plaintiff Fact Sheets for both individual and class action claims that the generic hypertension drugs contained cancer-causing impurities.…